iTonic (ITOC) vs InspireMD (NSPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
iTonic (ITOC) has outperformed InspireMD (NSPR) over the past year, losing 64.2% versus a loss of 80.3%. iTonic is the larger company by market cap ($29.4 million vs $22.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ITOC | NSPR |
|---|---|---|
| Share price | $4.02 | $0.48 |
| Market cap | $29.41M | $22.31M |
| 1-day change | -3.13% | -6.61% |
| YTD return | -40.32% | -73.03% |
| 1-year return | -64.16% | -80.33% |
| 5-year return | — | -88.68% |
| EPS (TTM) | $-4.22 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.40 | $2.54 |
| 52-week low | $3.42 | $0.46 |
| Distance from 52-week high | -78.15% | -81.10% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +593.75% |
| Average volume | 51.11K | 79.31K |
| Shares outstanding | 6.84M | 46.49M |
| Employees | 7 | 127 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ITOC has outperformed NSPR by 16.2 percentage points over the past year.
About iTonic
ITOC stock →iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Healthcare · Medical Devices · 7 employees
About InspireMD
NSPR stock →InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions.
Healthcare · Medical Devices · 127 employees
ITOC vs NSPR FAQ
Which is bigger, iTonic or InspireMD?
iTonic (ITOC) is larger, with a market capitalization of $29.41M compared with $22.31M for InspireMD (NSPR).
Which stock has performed better over the past year, ITOC or NSPR?
ITOC returned -64.16% over the past 12 months, compared with -80.33% for NSPR (price return, excluding dividends). Past performance does not predict future results.
Are iTonic and InspireMD in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.